New shot takes aim at genetic high cholesterol in major trial
NCT ID NCT07465263
First seen Mar 20, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This study tests an injection called SYH2053 in 135 adults with heterozygous familial hypercholesterolemia (HeFH), an inherited condition causing very high cholesterol and heart disease risk. Participants must already be on a stable statin and low-fat diet. The main goal is to see how much LDL (bad) cholesterol drops after 330 days. This is a Phase 3 trial, meaning it's a late-stage check for effectiveness and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.